A phase 2 trial of Vorolanib and Atezolizumab in Extensive-stage small-cell lung cancer, run by Washington University School of Medicine, recorded as terminated on the registry.
Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer is a phase 2 interventional study registered as NCT04373369 by Washington University School of Medicine, with 11 participants recorded, started 2020-10-07 and due to reach its primary completion in 2022-08-18. Interventions recorded: Vorolanib, Atezolizumab. Conditions recorded: Extensive-stage Small Cell Lung Cancer.
Linked to the drug Vorolanib because the registry names it among its interventions and Extensive-stage small-cell lung cancer among its conditions. Registry record only: no result has been read by an editor.
Numbers are from the trial as recorded here; see the source links in the table below. This is orientation, not medical advice: ask your team how closely the trial population matches you.
11 enrolled.
90% CI 8.9 to 49.8; Figures from the ClinicalTrials.gov results section (first posted 2023-06-02), not from a publication
Source90% CI 5.1 to 16.7; Figures from the ClinicalTrials.gov results section (first posted 2023-06-02), not from a publication
SourceThe full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Vorolanib and the tag pipeline.
Shares Vorolanib and the tag pipeline.
Shares Extensive-stage small-cell lung cancer and the tag pipeline.
Shares Extensive-stage small-cell lung cancer, Atezolizumab and the tag pipeline.
Shares Extensive-stage small-cell lung cancer and the tag pipeline.
Shares Atezolizumab and the tag pipeline.
Shares Atezolizumab and the tag pipeline.
Shares Atezolizumab and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/